Graviti Pharmaceuticals Private Limited FDA Record
- Latest inspection VAI · Jul 28, 2026
- No warning letters matched by name
Graviti Pharmaceuticals Private Limited has 3 FDA recalls, 2 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Graviti Pharmaceuticals Private Limited" is on file.
- Latest recall
- D-0293-2026 · Class II · Jan 10, 2026
- Latest inspection
- Jul 28, 2026 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 3 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 2 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Graviti Pharmaceuticals Private Limited: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 0 | 0 | 1 | 0 |
| 2025 | 0 | 0 | 0 | 1 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 1 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 1 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Graviti Pharmaceuticals Private Limited as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Graviti Pharmaceuticals Private Limited yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0293-2026 | Class II | Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals… | Jan 10, 2026 |
| D-0037-2026 | Class II | Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd… | Sep 15, 2025 |
| D-0832-2020 | Class II | Atorvastatin Calcium Tablets, USP, 10 mg*, 90-count bottle, Rx Only, Manufactured for: Biocon Pharma… | Jan 28, 2020 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jul 28, 2026 | Hyderabad, India | Drugs | Voluntary Action Indicated (VAI) | 3012932394 |
| Feb 3, 2023 | Hyderabad, India | Drugs | No Action Indicated (NAI) | 3012932394 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3012932394 | Hyderabad, India | 2 | Jul 28, 2026 |
Graviti Pharmaceuticals Private Limited and the FDA: common questions
Has Graviti Pharmaceuticals Private Limited received an FDA warning letter?
No FDA warning letter addressed to the name "Graviti Pharmaceuticals Private Limited" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Graviti Pharmaceuticals Private Limited received an FDA Form 483?
FDA has not published a Form 483 for "Graviti Pharmaceuticals Private Limited" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Graviti Pharmaceuticals Private Limited?
The most recent FDA inspection on file ended Jul 28, 2026 at Hyderabad, India and was classified VAI. FDA has 2 inspections of Graviti Pharmaceuticals Private Limited on file.
Has Graviti Pharmaceuticals Private Limited had an FDA recall?
Yes. Graviti Pharmaceuticals Private Limited has 3 FDA recalls on record. The most recent started Jan 10, 2026.
Need more than this page shows? Ask about Graviti Pharmaceuticals Private Limited in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.